GSKH · ARCA · ETF
GSK plc ADRhedged (GSKH) Price, Holdings & Fees
GSK plc ADRhedged (GSKH) closed at $985.83 on Oct 9, 2026, up 1.16% from the previous close of $974.52.
Share price, past year
1Y −0.38%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $985.83 |
| Sep 30, 2026 | $1,030.94 |
| Aug 31, 2026 | $1,103.20 |
| Jul 31, 2026 | $1,035.77 |
| Jun 30, 2026 | $986.00 |
| May 29, 2026 | $998.42 |
| Apr 30, 2026 | $982.47 |
| Mar 31, 2026 | $929.32 |
| Feb 27, 2026 | $951.83 |
| Jan 30, 2026 | $988.35 |
| Dec 31, 2025 | $1,015.45 |
| Nov 28, 2025 | $985.47 |
| Oct 31, 2025 | $996.58 |
Key statistics
- Expense ratio
- 0.19%
- as of Apr 30, 2026
- Net assets
- $737.4K
- as of Jun 30, 2026
- Holdings
- 3
- as of Jun 30, 2026
- 52-week range
- $915.28 – $1,135.72
GSK plc ADRhedged's expense ratio is 0.19%: $19.00 a year on $10,000 invested.
Holdings
GSK plc ADRhedged held 3 investments worth $737.44K as of Jun 30, 2026. Its largest holding was GSK PLC, at 96.79% of the fund.
| # | Holding | % of fund | Value |
|---|---|---|---|
| 1 | GSK PLCGSK | 96.79% | $713.80K |
| 2 | DREYFUS TRSRY SECURITIES | 2.57% | $18.92K |
| 3 | CANADIAN IMPERIAL BANK OF COMMERCE | −0.19% | −$1.41K |
Top 3 of 3 holdings, as of Jun 30, 2026. Percentages are of the fund's net assets.
What the fund owns
| Asset type | % of fund |
|---|---|
| Stocks | 96.79% |
| Cash and short-term investments | 2.57% |
| Currency derivatives | −0.19% |
| Country | % of fund |
|---|---|
| United Kingdom | 96.79% |
| United States | 2.57% |
| Canada | −0.19% |
Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.
Monthly total returns
Over the 3 months to Jun 30, 2026, GSK plc ADRhedged's total return was −5.04%, as reported to the SEC.
| Month | Total return |
|---|---|
| Jun 30, 2026 | +5.05% |
| May 31, 2026 | −1.77% |
| Apr 30, 2026 | −7.98% |
The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.
Fund profile
- Name
- GSK plc ADRhedged
- Ticker
- GSKH
- Exchange
- ARCA
- Fund type
- ETF
- Trust
- Precidian ETFs Trust
- SEC series ID
- S000058701
- SEC CIK
- 0001499655
- Fractional shares
- No
Recent SEC filings
- Aug 21, 2026
- Sep 4, 2026
- 485BPOSProspectus updateApr 29, 2026
- Mar 5, 2026
- Aug 28, 2025
- 485BPOSProspectus updateApr 30, 2025
- Mar 7, 2025
- 485BPOSProspectus updateFeb 28, 2025
Shareholder reports and prospectuses are filed by Precidian ETFs Trust, the trust behind GSK plc ADRhedged, and cover all of its funds.
Frequently asked questions
What is GSKH's price?
GSK plc ADRhedged (GSKH) closed at $985.83 on Oct 9, 2026, up 1.16% from the previous close of $974.52.
What is GSKH's expense ratio?
GSK plc ADRhedged's expense ratio is 0.19%: $19.00 a year on $10,000 invested.
What does GSKH hold?
GSK plc ADRhedged held 3 investments worth $737.44K as of Jun 30, 2026. Its largest holding was GSK PLC, at 96.79% of the fund. Its five largest holdings were GSK PLC, DREYFUS TRSRY SECURITIES, CANADIAN IMPERIAL BANK OF COMMERCE.
How has GSKH performed?
Over the 3 months to Jun 30, 2026, GSK plc ADRhedged's total return was −5.04%, as reported to the SEC.
Sources and methodology
Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jun 30, 2026 (filed Aug 21, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Apr 30, 2026. Prices are generated sample data for development. Data sources and disclosures